The board of directors of healthcare company Eli Lilly and Company (NYSE:LLY) declare a dividend of USD0.74 per share on the company's outstanding common stock for the second quarter of 2020, it disclosed on Monday
This dividend is due on 10 June 2020 to shareholders of record at the close of business as of 15 May 2020.
Lilly is engaged in the discovery of medicines that make life better for people around the world.
Across the globe, the company said its employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease and give back to communities through philanthropy and volunteerism.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development